Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of neural transmission

• Publication date

  2010-01-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00702-009-0357-zPMID 20052506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.

  2010cited by this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cited by this paper
• Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: An fMRI study

  2009influential reference
• Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days.

  2008influential reference
• Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana.

  2008cited by this paper
• MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.

  2008influential reference
• Serotonin and sleep : molecular, functional and clinical aspects

  2008cited by this paper
• Effect of the selective activation of serotonin 5-HT3 receptors on sleep and waking

  2008cited by this paper
• The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

  2008cited by this paper
• Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms

  2007cited by this paper
• The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

  2007cited by this paper
• Linking Increasing Drought Stress to Scots Pine Mortality and Bark Beetle Infestations

  2007cited by this paper
• 5-HT3 receptor-mediated photic-like responses of the circadian clock in the rat.

  2007cited by this paper
• Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.

  2006cited by this paper
• Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns

  2006cited by this paper
• Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

  2005cited by this paper
• Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse

  2005cited by this paper
• Despite Similar Anxiolytic Potential, the 5-Hydroxytryptamine 2C Receptor Antagonist SB-242084 [6-Chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl Carbamoyl] Indoline] and Chlordiazepoxide Produced Differential Effects on Electroencephalogram Power Spectra

  2005cited by this paper
• Turning behaviour induced by stimulation of the 5‐HT receptors in the subthalamic nucleus

  2004cited by this paper
• Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA

  2004influential reference
• Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density

  2003cited by this paper
• Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

  2001cited by this paper
• Involvement of 5‐HT3 receptors in the nucleus accumbens in the potentiation of cocaine‐induced behaviours in the rat

  2000cited by this paper
• Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.

  2000cited by this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cited by this paper
• Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.

  1998cited by this paper
• Hippocampal theta: a sensory-inhibition theory of function.

  1998cited by this paper
• Interactions between the serotoninergic and noradrenergic systems of the brain and their role in the regulation of animal behavior

  1997cited by this paper
• Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat.

  1997cited by this paper
• 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum.

  1996cited by this paper
• The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

  1995cited by this paper
• Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies.

  1995cited by this paper
• Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat

  1995cited by this paper
• Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats

  1995cited by this paper
• The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.

  1993cited by this paper
• Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.

  1993cited by this paper
• Effects of the combined administration of the 5-HT3 antagonist MDL 72222 and ethanol on conditioning in the periadolescent and adult rat.

  1993cited by this paper
• Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.

  1993cited by this paper
• Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain.

  1993cited by this paper
• Autoradiography of [3H]quipazine in rodent brain.

  1990cited by this paper
• Identification and distribution of 5-HT3 recognition sites within the human brainstem.

  1990cited by this paper
• The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.

  1990cited by this paper
• Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

  1990cited by this paper
• Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

  1990cited by this paper
• Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices.

  1990cited by this paper
• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

  1989cited by this paper
• The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

  1988cited by this paper
• The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.

  1988cited by this paper
• Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning.

  1988cited by this paper
• Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

  1987cited by this paper
• Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

  1987cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987cited by this paper
• Origin of the neocortically monitored theta rhythm in the curarized rat.

  1978cited by this paper
• Volume conduction and EEG measurements within the brain: a quantitative approach to the influence of electrical spread on the linear relationship of activity measured at different locations.

  1977cited by this paper

• Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

  2022cites this paper
• Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats

  2018cites this paper
• Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism

  2015cites this paper
• Disturbances in slow‐wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats

  2013cites this paper
• Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats

  2013cites this paper
• Exploring the impact of ecstasy on retinal physiology: A pioneer study

  2012cites this paper
• Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models.

  2012cites this paper